Department of Cutaneous Allergy, St John's Institute of Dermatology, St Thomas' Hospital, SE1 7EH London, UK.
Clin Dermatol. 2011 May-Jun;29(3):257-65. doi: 10.1016/j.clindermatol.2010.11.003.
Cutaneous inflammation can show Th1 or Th2 predominance, but the precise mechanisms by which such selectivity is determined are unknown. A recent study has demonstrated that Th1 cells, but not Th2 cells, produce an endogenous ligand for Toll-like receptor (TLR) 4, namely extradomain A+ fibronectin containing extra type III domain A (FnEDA+). As TLR4 stimulation leads to production of proinflammatory cytokines that recruit (via altered endothelial adhesion molecule expression and chemokine production) more Th1/Th17 cells, a positive feedback mechanism for Th1/Th17 inflammation exists. We propose that FnEDA+ positive feedback loops are a potential driver of Th1/Th17 inflammation. Conversely, the inflammatory EDA+ fibronectin loop is negatively regulated in atopic dermatitis, Th2 cytokines actively suppress TLR4 expression of Th1 cytokines, and recruited Th2 cells do not produce FnEDA+. In psoriasis, there are multiple FnEDA+ loops, comprising inflammatory, keratinocyte, and autoimmune loops. In allergic contact dermatitis, a single inflammatory loop operates. In atopic dermatitis, the FnEDA+ loop is actively suppressed by Th2 cytokines, and recruited Th2 cells do not "feedback" FnEDA+. We review endogenous ligands for TLR in relation to inflammatory disease, FnEDA+ function, and the potential role for FnEDA+ in psoriasis, allergic contact dermatitis, and atopic dermatitis.
皮肤炎症可表现为 Th1 或 Th2 优势,但尚不清楚决定这种选择性的确切机制。最近的一项研究表明,Th1 细胞而不是 Th2 细胞产生 Toll 样受体(TLR)4 的内源性配体,即含有额外 III 型域 A 的外结构域 A+纤连蛋白(FnEDA+)。由于 TLR4 刺激导致产生募集(通过改变内皮细胞黏附分子表达和趋化因子产生)更多 Th1/Th17 细胞的促炎细胞因子,因此存在 Th1/Th17 炎症的正反馈机制。我们提出 FnEDA+正反馈环是 Th1/Th17 炎症的潜在驱动因素。相反,在特应性皮炎中,EDA+纤连蛋白环受到炎症的负调控,Th2 细胞因子积极抑制 Th1 细胞因子的 TLR4 表达,募集的 Th2 细胞不产生 FnEDA+。在银屑病中,存在多个 FnEDA+环,包括炎症、角质形成细胞和自身免疫环。在过敏性接触性皮炎中,只有一个炎症环起作用。在特应性皮炎中,Th2 细胞因子积极抑制 FnEDA+环,募集的 Th2 细胞不“反馈”FnEDA+。我们回顾了 TLR 与炎症性疾病、FnEDA+功能相关的内源性配体,以及 FnEDA+在银屑病、过敏性接触性皮炎和特应性皮炎中的潜在作用。